JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.76 Billion JPY | 134.93% |
| 2022 | 750 Million JPY | -77.22% |
| 2021 | 3.29 Billion JPY | 95.14% |
| 2020 | 1.68 Billion JPY | -56.4% |
| 2019 | 3.86 Billion JPY | 24.93% |
| 2018 | 3.09 Billion JPY | 11.93% |
| 2017 | 2.76 Billion JPY | 39.75% |
| 2016 | 1.98 Billion JPY | 4.1% |
| 2015 | 1.9 Billion JPY | 52.75% |
| 2014 | 1.24 Billion JPY | -63.58% |
| 2013 | 3.41 Billion JPY | 213.84% |
| 2012 | 1.08 Billion JPY | 183.72% |
| 2011 | 384 Million JPY | 65.13% |
| 2010 | 232.54 Million JPY | 1354.49% |
| 2009 | -18.53 Million JPY | 83.58% |
| 2008 | -112.88 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 1.61 Billion JPY | 65.51% |
| 2024 Q1 | 579 Million JPY | 248.84% |
| 2024 Q2 | 977 Million JPY | 68.74% |
| 2023 Q3 | 1.37 Billion JPY | 248.23% |
| 2023 FY | 1.76 Billion JPY | 134.93% |
| 2023 Q4 | -389 Million JPY | -128.21% |
| 2023 Q1 | 376 Million JPY | 236.23% |
| 2023 Q2 | 396 Million JPY | 5.32% |
| 2022 Q1 | 433 Million JPY | -20.99% |
| 2022 FY | 750 Million JPY | -77.22% |
| 2022 Q4 | -276 Million JPY | -91.67% |
| 2022 Q3 | -144 Million JPY | -119.54% |
| 2022 Q2 | 737 Million JPY | 70.21% |
| 2021 Q3 | 831 Million JPY | -46.18% |
| 2021 Q4 | 548 Million JPY | -34.06% |
| 2021 Q1 | 369 Million JPY | -78.32% |
| 2021 Q2 | 1.54 Billion JPY | 318.43% |
| 2021 FY | 3.29 Billion JPY | 95.14% |
| 2020 Q3 | -2.07 Billion JPY | -268.94% |
| 2020 Q1 | 833 Million JPY | -3.7% |
| 2020 Q2 | 1.23 Billion JPY | 47.66% |
| 2020 Q4 | 1.7 Billion JPY | 181.91% |
| 2020 FY | 1.68 Billion JPY | -56.4% |
| 2019 FY | 3.86 Billion JPY | 24.93% |
| 2019 Q3 | 1.56 Billion JPY | 65.71% |
| 2019 Q1 | 501 Million JPY | -41.88% |
| 2019 Q2 | 942 Million JPY | 88.02% |
| 2019 Q4 | 865 Million JPY | -44.59% |
| 2018 Q4 | 862 Million JPY | -28.23% |
| 2018 Q1 | 166 Million JPY | -75.22% |
| 2018 Q2 | 868 Million JPY | 422.89% |
| 2018 Q3 | 1.2 Billion JPY | 38.36% |
| 2018 FY | 3.09 Billion JPY | 11.93% |
| 2017 FY | 2.76 Billion JPY | 39.75% |
| 2017 Q4 | 670 Million JPY | -44.31% |
| 2017 Q3 | 1.2 Billion JPY | 131.35% |
| 2017 Q2 | 520 Million JPY | 39.04% |
| 2017 Q1 | 374 Million JPY | -56.61% |
| 2016 FY | 1.98 Billion JPY | 4.1% |
| 2016 Q4 | 862 Million JPY | 30.41% |
| 2016 Q3 | 661 Million JPY | 53.36% |
| 2016 Q2 | 431 Million JPY | 1557.69% |
| 2016 Q1 | 26 Million JPY | -96.06% |
| 2015 Q1 | 48 Million JPY | -52.01% |
| 2015 Q4 | 660.18 Million JPY | -26.28% |
| 2015 Q3 | 895.53 Million JPY | 200.19% |
| 2015 Q2 | 298.32 Million JPY | 521.51% |
| 2015 FY | 1.9 Billion JPY | 52.75% |
| 2014 Q4 | 100.01 Million JPY | -86.82% |
| 2014 FY | 1.24 Billion JPY | -63.58% |
| 2014 Q3 | 759.03 Million JPY | 140.11% |
| 2014 Q2 | 316.12 Million JPY | 351.52% |
| 2014 Q1 | 70.01 Million JPY | -90.83% |
| 2013 Q4 | 763.51 Million JPY | 52.16% |
| 2013 Q3 | 501.78 Million JPY | -63.85% |
| 2013 FY | 3.41 Billion JPY | 213.84% |
| 2013 Q1 | 766.02 Million JPY | 64.22% |
| 2013 Q2 | 1.38 Billion JPY | 81.2% |
| 2012 Q3 | 203.69 Million JPY | -42.15% |
| 2012 Q4 | 466.46 Million JPY | 129.01% |
| 2012 FY | 1.08 Billion JPY | 183.72% |
| 2012 Q1 | 67.23 Million JPY | -54.33% |
| 2012 Q2 | 352.12 Million JPY | 423.69% |
| 2011 Q4 | 147.22 Million JPY | -6.59% |
| 2011 Q2 | 305.87 Million JPY | 234.92% |
| 2011 Q3 | 157.61 Million JPY | -48.47% |
| 2011 Q1 | -226.7 Million JPY | -1337.55% |
| 2011 FY | 384 Million JPY | 65.13% |
| 2010 Q3 | 89.48 Million JPY | -57.7% |
| 2010 FY | 232.54 Million JPY | 1354.49% |
| 2010 Q1 | -86.79 Million JPY | -2018.99% |
| 2010 Q4 | 18.31 Million JPY | -79.53% |
| 2010 Q2 | 211.53 Million JPY | 343.72% |
| 2009 Q3 | 37.84 Million JPY | -44.36% |
| 2009 Q1 | -120.31 Million JPY | 0.0% |
| 2009 Q4 | -4.09 Million JPY | -110.82% |
| 2009 Q2 | 68.02 Million JPY | 156.54% |
| 2009 FY | -18.53 Million JPY | 83.58% |
| 2008 FY | -112.88 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 190197.455% |
| Ansell Limited | 76.5 Million USD | -2203.268% |
| Ansell Limited | 76.5 Million USD | -2203.268% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -7156.942% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 108182.047% |
| Psykey, Inc. | -1.32 Million USD | 133186.496% |
| ConvaTec Group Plc | 130.3 Million USD | -1252.264% |
| ConvaTec Group Plc | 130.3 Million USD | -1252.264% |
| Encision Inc. | -691.78 Thousand USD | 254804.149% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 1242598.819% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 751915.536% |
| Innovative MedTech Inc. | -7.93 Million USD | 22294.519% |
| LifePoint, Inc. | -15.23 Million USD | 11668.058% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 25969.916% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 371829.958% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 642120.653% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 383954.58% |
| SmileDirectClub, Inc. | -86.4 Million USD | 2139.257% |
| Sector 10, Inc. | 7036.00 USD | -25042537.862% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 11.984% |
| SheerVision, Inc. | -71.37 Thousand USD | 2468716.902% |
| United Health Products, Inc. | -2.62 Million USD | 67268.153% |
| Vasamed, Inc. | -4.88 Million USD | 36146.335% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 73871.168% |
| Yubo International Biotech Limited | -1.2 Million USD | 146352.589% |